FdaApplication
BLA 761090
Identifiers
- fda_app_no: BLA761090
Properties
| Property | Value |
|---|---|
| applicant_name | Takeda Pharmaceuticals U.S.A., Inc. |
| application_type | BLA |
| approval_date | 2018-08-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAKHZYRO | LANADELUMAB-FLYO | 300MG/2ML (150MG/ML) | Injection |
| TAKHZYRO | LANADELUMAB-FLYO | 300MG/2ML (150MG/ML) | Injection |
| TAKHZYRO | — | 150MG/1ML (150MG/ML) | Injection |
3 products